Scarica l'app Stockscreener
1.1511
0.00%
0.0011
Precedente Chiudi:
$1.15
Aprire:
$1.14
Volume 24 ore:
11,188
Relative Volume:
0.02
Capitalizzazione di mercato:
$5.15M
Reddito:
$8.97M
Utile/perdita netta:
$-15.21M
Rapporto P/E:
-0.00988
EPS:
-116.51
Flusso di cassa netto:
$-10.84M
1 W Prestazione:
-11.20%
1M Prestazione:
-10.85%
6M Prestazione:
-15.44%
1 anno Prestazione:
-91.80%
Intervallo 1D:
$1.14
$1.1778
Intervallo di 1 settimana:
$1.102
$1.34
Portata 52W:
$0.9237
$16.62
Nuwellis Inc Stock (NUWE) Company Profile
Nome
Nuwellis Inc
Settore
Industria
Telefono
952-345-4200
Indirizzo
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Confronta NUWE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
1.1511 | 5.15M | 8.97M | -15.21M | -10.84M | -116.51 |
|
ABT
Abbott Laboratories
|
126.09 | 221.85B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
96.89 | 142.24B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
370.31 | 140.07B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
93.08 | 118.98B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.66 | 40.31B | 5.72B | 4.17B | 259.90M | 6.97 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-29 | Iniziato | ROTH MKM | Buy |
Nuwellis Inc Borsa (NUWE) Ultime notizie
Nuwellis, Inc. Earnings Call: Mixed Results with Promising Prospects - TipRanks
Nuwellis, Inc. Reports 2024 Financial Results and Strategic Progress - TipRanks
Earnings call transcript: Nuwellis Q4 2024 sees improved margins, stock dips - Investing.com Canada
Nuwellis price target lowered to $13 from $16 at Roth MKM - TipRanks
Earnings call transcript: Nuwellis Q4 2024 sees improved margins, stock dips By Investing.com - Investing.com South Africa
Nuwellis, Inc. (NUWE) Reports Q4 Loss, Lags Revenue Estimates (Revised) - Yahoo Finance
Nuwellis Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Medical device maker Nuwellis posts fourth-quarter sales of $2.3 mln -March 11, 2025 at 09:08 am EDT - Marketscreener.com
Nuwellis, Inc. (NUWE) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Nuwellis reports Q4 EPS (44c) vs ($54.48) last year - TipRanks
Nuwellis Earnings Show Major Medicare Win: 4X Payment Boost Coming as Critical Care Surges - StockTitan
Nuwellis (NUWE) Projected to Post Earnings on Tuesday - Defense World
Nuwellis, Inc. to Host Earnings Call - ACCESS Newswire
Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO - The Manila Times
Nuwellis Appoints John Erb as Interim CEO - MSN
Nuwellis announces CEO retirement - MSN
Nuwellis Announces Retirement Of Nestor Jaramillo, Jr. As President And CEO -February 24, 2025 at 05:07 pm EST - Marketscreener.com
Nuwellis announces leadership transition with interim CEO By Investing.com - Investing.com Canada
Nuwellis announces leadership transition with interim CEO - Investing.com India
Can Nuwellis' Former CEO Steady the Ship? Key Details of Leadership Shuffle - StockTitan
JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis - The Manila Times
Nuwellis, Inc. Reports 60% Reduction in Heart Failure Events with Aquadex® SmartFlow Ultrafiltration Therapy in Updated AVOID-HF Study Analysis - Nasdaq
Revolutionary Heart Failure Treatment Cuts Patient Events by 60%New Study Reveals Why It Matters - StockTitan
Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025 - The Manila Times
Nuwellis, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025 - Nasdaq
Nuwellis Financial Results: Strategic Update and 2024 Performance Review Coming Next Month - StockTitan
Short Interest in Nuwellis, Inc. (NASDAQ:NUWE) Rises By 67.8% - Defense World
Nuwellis (NASDAQ:NUWE) Stock Price Up 2.4% – Here’s What Happened - Defense World
Nuwellis Inc (NUWE) produces promising results - US Post News
Market Highlights: Nuwellis Inc (NUWE) Ends on a Low Note at 1.21 - The Dwinnex
Update on Alert: Extracorporeal Blood Circuit Issue from Nuwellis - FDA.gov
Xcorporeal (OTCMKTS:XCRP) versus Nuwellis (NASDAQ:NUWE) Critical Review - Defense World
Roth Capital Has Optimistic View of Nuwellis FY2024 Earnings - Defense World
Equities Analysts Issue Forecasts for Nuwellis Q1 Earnings - Defense World
Nuwellis Stock Spikes After Reimbursement Hike: Retail’s Upbeat - MSN
Nuwellis Adds Nationally Ranked Utah Hospital as New Pediatric Customer for Aquadex SmartFlow® Therapy - The Manila Times
Nuwellis Expands Pediatric Reach: Aquadex SmartFlow System Adopted by Major Utah Hospital - StockTitan
FDA issues early alert against Nuwellis’ extracorporeal blood circuits - Medical Buyer
FDA And Nuwellis Address Potentially High-Risk Issue With Blood Circuit Device - AOL
FDA issues “high-risk” safety alert to Nuwellis blood circuit sets - Yahoo Finance
FDA says aware Nuwellis recalling certain blood circuit lots - TipRanks
CHF Solutions, Inc. Receives Registration from FDA Thailand to Allow the Sale of Aquadex Flex Flow® in Thailand - Marketscreener.com
Nuwellis regains Nasdaq compliance with bid and equity rules - Investing.com
Nuwellis Regains Compliance with Nasdaq Listing Requirements - The Manila Times
Nuwellis Secures Nasdaq Listing Future After Meeting Critical Compliance Requirements - StockTitan
Nuwellis announces voluntary recall of blood circuit lots - Investing.com
Earnings call: Nuwellis reports mixed Q3 results amid segment shifts By Investing.com - Investing.com Nigeria
Nuwellis (ASX:SHC) Profitability Rank : 1 (As of Sep. 2024) - GuruFocus.com
Nuwellis (ASX:SHC) 3-Year FCF Growth Rate : 73.20% (As of Sep. 2024) - GuruFocus.com
Nuwellis, Inc. (NUWE) Q3 Earnings Surpass Estimates - MSN
Nuwellis Inc Azioni (NUWE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.57%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):